Minimally Invasive Direct Aortic Implantation of Impella 5.5 As Bridge to Transplant: A Case Report

Transplant Proc. 2024 Jan-Feb;56(1):145-147. doi: 10.1016/j.transproceed.2023.10.006. Epub 2024 Jan 3.

Abstract

The use of temporary mechanical circulatory support in cardiogenic shock (CS) is increasing. The Impella (Abiomed) is a percutaneous, microaxial ventricular assist device approved for short-term use in CS that can be implanted peripherally. Direct aortic placement is an alternative commonly performed when the sternum is open, for example, in post-cardiotomy shock or when the peripheral vasculature is of insufficient size or quality for implantation. Herein, we describe direct aortic implantation of the Impella 5.5 via right mini-thoracotomy for a patient in CS secondary to decompensated heart failure as a bridge to candidacy and, ultimately, transplantation.

Publication types

  • Case Reports

MeSH terms

  • Aorta
  • Heart Failure* / complications
  • Heart Failure* / surgery
  • Heart-Assist Devices* / adverse effects
  • Humans
  • Retrospective Studies
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / surgery
  • Treatment Outcome